Related Experiment Video

Updated: May 25, 2026

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation
08:04

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation

Published on: July 9, 2014

Non-viral infections in children after renal transplantation

Francesca Mencarelli1, Stephen D Marks

  • 1Department of Paediatric Nephrology, Great Ormond Street Hospital for Children NHS Trust, Great Ormond Street, London, WC1N 3JH, England, UK.

Pediatric Nephrology (Berlin, Germany)
|February 10, 2012
PubMed

Insights

Non-viral infections are a serious risk for pediatric kidney transplant recipients (RTR). This review examines infection risks, prevention, and treatment to improve patient outcomes and allograft survival.

Area of Science:

  • Pediatric Nephrology
  • Transplant Immunology
  • Infectious Diseases

Background:

  • Renal transplantation is the optimal treatment for pediatric end-stage renal failure.
  • Advances in immunosuppression and surgical techniques have improved patient and graft survival.
  • Non-viral infections remain a significant complication for pediatric renal transplant recipients (RTR).

Purpose of the Study:

  • To review the incidence, timing, risk factors, prevention, and treatment of non-viral infections in pediatric RTR.
  • To critically evaluate current immunosuppressive regimens and their risk-benefit ratio.
  • To optimize renal allograft survival while minimizing infectious complications.

Main Methods:

  • Literature review of non-viral infections in pediatric renal transplant recipients.
  • Analysis of risk factors including immunization status, pathogen exposure, and immunosuppression levels.
  • Evaluation of infection sources: donor-derived, transplant fluids, catheters, and stents.
  • Review of urinary tract infection prevalence in patients with lower urinary tract dysfunction.

Main Results:

  • High immunosuppression burden in the first 6 months post-transplant increases the risk of life-threatening infections, including Cytomegalovirus.
  • Bacterial infections can originate from various sources related to the transplant procedure and devices.
  • Urinary tract infections are common and can lead to renal allograft damage, especially in patients with lower urinary tract dysfunction.

Conclusions:

  • Optimizing immunosuppressive regimens is crucial for balancing rejection prevention and infection risk in pediatric RTR.
  • Proactive management of infection risks, including appropriate prophylaxis and monitoring, is essential.
  • Further research into risk stratification and targeted prevention strategies can improve long-term outcomes for pediatric kidney transplant recipients.

More Related Videos

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant08:52

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Published on: May 27, 2011

Related Concept Videos

Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Acute Pyelonephritis I: Introduction01:27

Acute Pyelonephritis I: Introduction

Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such as Proteus,...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...